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Introduction
Blood vessels play a critical role in the delivery of oxygen and 
nutrients throughout the body. The capillary bed of each tissue 
is comprised of endothelial cell (ECs), which form the walls 
of the blood vessels, and pericytes, which sit on the abluminal 
surface of the endothelial tube. In the central nervous system 
(CNS), ECs contain a series of specialized properties, termed 
the blood–brain barrier (BBB), that allows them to protect neu-
ral cells from blood-borne toxic molecules, pathogens, and fluc-
tuations of ion concentrations. CNS ECs are held together by 
tight junctions (TJs), which generate a tight paracellular barrier, 
undergo extremely low rates of transcytosis, and contain highly 
specific transport mechanisms. Together, these properties allow 
CNS ECs to tightly regulate the movement of solutes between 
the blood and the brain (Daneman, 2012; Siegenthaler et al., 
2013; Sohet and Daneman, 2013). Loss of these barrier proper-
ties in different diseases including multiple sclerosis (MS), stroke, 
Alzheimer’s disease, and epilepsy can lead to neuronal dysfunc-
tion and degeneration (Daneman, 2012). Thus, understanding 
the molecular mechanisms that regulate barrier properties might 
help in the discovery of new therapeutic targets that could help 
restore the BBB in patients with different neurological diseases.
The formation of the paracellular TJs is critical for this 
barrier, as it generates polarized cells with distinct luminal and 
abluminal composition, allowing transport properties to deter-
mine the movement of molecules across the cell barrier. TJs, 
first characterized by studies in epithelial cells, are formed by 
intercellular adhesions between the transmembrane proteins 
claudins, occludin, and junctional adhesion molecules (JAMs), 
which are linked to the cytoskeleton and adherens junctions 
by adaptor molecules such as zonula occludens (ZO) proteins. 
Claudins, a family of tetraspanin genes with >20 members in 
mammals (Günzel and Yu, 2013), form homotypic and hetero-
typic interactions that are critical for the paracellular barrier 
in different epithelial cells. Claudins are expressed in a tissue-
specific manner, and the specific claudin family member deter-
mines the specific permeability of the TJ in each tissue. Claudin 
5 is the major TJ protein expressed in ECs, and Cldn5 knock-
out mice die at birth with a BBB leaky to small molecules 
The blood–brain barrier (BBB) is a term used to de-scribe the unique properties of central nervous system (CNS) blood vessels. One important BBB property 
is the formation of a paracellular barrier made by tight 
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tricellular junctions and that its expression correlates with 
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bryogenesis in Lsr knockout mice with a leakage to small 
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rupted, including an experimental autoimmune encepha-
lomyelitis (EAE) model of multiple sclerosis and a middle 
cerebral artery occlusion (MCAO) model of stroke, LSR 
was down-regulated, linking loss of LSR and pathological 
BBB leakage.
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Results and discussion
LSR is expressed at tricellular TJs  
in CNS ECs
We first examined LSR expression in different organs by immuno-
staining tissue sections of brain, liver, lung, and intestine for 
LSR and double-labeling for ECs with an antibody directed 
against CD31 (Fig. 1 A). In each of these organs there is robust 
LSR expression. However, LSR expression only colocalizes 
with CD31+ ECs in the brain and not in the peripheral organs. 
In the peripheral tissues, LSR staining is restricted to epithelial 
cells (lung, intestine) or hepatocytes (liver). These results con-
firm that Lsr is highly enriched in brain ECs compared with 
liver, lung, and intestinal ECs.
To precisely define LSR sublocalization, we performed 
triple-labeling of mouse brain tissue sections with BSL I (to 
label endothelial membranes), occludin (a marker of the bicel-
lular TJ), and LSR. High-magnification images demonstrate 
that occludin stains bicellular TJ, whereas LSR has a punctate 
expression localized to points where multiple occludin bicel-
lular TJs meet, i.e., the tricellular junction (Fig. 1 B). Although 
LSR is largely enriched at the tricellular junction, lower expres-
sion levels can also be observed at the bicellular junctions. We 
observed the same expression pattern throughout the mouse 
brain and SC in all capillaries, arteries, and veins (Fig. S1 A), 
with the notable exceptions of the vessels in the choroid plexus 
and circumventricular organs. In the choroid plexus, LSR is 
localized at tricellular TJ of the tight epithelial cells but is ab-
sent from the leaky vessels (Fig. S1 B). LSR expression is also 
absent from the ECs of the circumventricular organs, which 
contain leaky vessels that are not part of the BBB (Fig. S1 A). 
Therefore, LSR protein in CNS ECs is largely expressed at the 
tricellular junctions of BBB-possessing vessels, which confirms 
a similar recent observation (Iwamoto et al., 2014).
We sought to determine the time course of LSR expres-
sion during development. Angiogenesis in the mouse CNS ini-
tiates at E9, and proceeds in a caudal-to-rostral direction. We 
examined LSR expression in the CNS of embryos from E10 
onwards (Fig. 2). At E11.5, LSR is expressed throughout the cel-
lular membrane of CNS ECs only at the caudal part of the SC. 
By E12.5, LSR expression is still diffuse throughout the EC 
membrane, but is expressed in vessels throughout the caudal– 
rostral axis of the SC and is absent from forebrain ECs. At 
E13.5, LSR is expressed in all blood vessels throughout the 
CNS including the brain, but this expression still appears to be 
diffuse throughout the EC membrane. Thus, LSR expression 
follows angiogenesis in a caudal-to-rostral direction from E11.5 
to E13.5. At postnatal day 3 (P3), LSR is localized mainly at 
the bicellular/tricellular TJs, whereas at P12 the protein is fur-
ther accumulated at the tricellular TJ and by P21 the protein is 
largely enriched at the tricellular junction as it is in the adult 
(Fig. S1 C and Fig. 1 B). Our results indicate that CNS EC 
expression of LSR follows slightly behind CNS angiogenesis, 
and as development proceeds more LSR is concentrated at the 
tricellular TJ of CNS blood vessels.
Lsr is made of 10 exons with three different splice vari-
ants: , , and  (Yen et al., 2008; Stenger et al., 2012a). The 
(<800 D; Nitta et al., 2003). Claudin 5 is expressed by ECs in 
many tissues and thus its expression alone does not confer the 
high resistance barrier that is specific to CNS ECs (Morita et al., 
1999). Claudin 3 and claudin 12 have also been described in 
CNS ECs (Nitta et al., 2003; Liebner et al., 2008); however, 
their exact roles remain to be investigated. Occludin, also a tet-
raspanin, is expressed in all epithelial cells and its expression 
in ECs is enriched in the barrier containing ECs of the CNS 
(Hirase et al., 1997; Daneman et al., 2010a). Occludin-deficient 
mice, however, do not exhibit BBB leakage, only calcification 
of the brain (Saitou et al., 2000). Thus, although several com-
ponents of the BBB TJs have been identified, it remains unclear 
why CNS ECs, but not ECs in other tissues, form these high-
resistance TJs.
Ikenouchi et al. (2005) described tricellulin, a new subtype 
of TJ protein expressed in epithelial cells at points where three 
cells meet. More recently, in epithelial cells, Lipolysis-stimulated 
lipoprotein receptor (LSR) was described as a tricellular TJ pro-
tein required to recruit tricellulin to the epithelial tricellular TJs 
(Masuda et al., 2011). LSR contains an extracellular N-terminal 
Ig domain followed by a single transmembrane region and a 
cytoplasmic C-terminal tail (Stenger et al., 2012a). The original 
role of the protein was described in lipid metabolism studies, as 
LSR was first discovered to be expressed in hepatocytes, where 
it plays a role in the clearance of triglyceride-rich lipoproteins 
and low-density lipoproteins, and also acts as a apolipoprotein 
B/E–containing lipoprotein receptor (Stenger et al., 2012a). Lsr 
knockout mice die before embryonic day 15.5 (E15.5), but the 
cause of death remains unclear (Mesli et al., 2004). Two addi-
tional members of the tricellular TJ family were described in mice 
epithelial cells, both LSR-related proteins: immunoglobulin-like 
domain containing receptor ILDR1 and ILDR2 (Higashi et al., 
2013). LSR, ILDR1, and ILDR2 share a complementary expres-
sion in many epithelium and all recruit tricellulin. Therefore, 
these three proteins have been named the angulin family, with 
angulin-1 (LSR), angulin-2 (ILDR1), and angulin-3 (ILDR2).
Previously, using EC purification and microarray analy-
sis, we were able to compare the gene expression of CNS ECs 
with ECs from the liver and lung, identifying a dataset of BBB-
enriched genes (Daneman et al., 2010a). Interestingly, tricel-
lulin and LSR were both enriched in CNS ECs compared with 
peripheral ECs, which suggests that tricellular junctions may be 
critical for the formation of the BBB. Here, we find that LSR 
is expressed at the tricellular TJ in mice brain and spinal cord 
(SC) ECs, but not in ECs in peripheral tissues. We describe 
LSR expression during development and show that it follows 
CNS angiogenesis and correlates with BBB formation during 
embryogenesis. Using dye injections into developing embryos, 
we show that in wild-type mice the BBB seals during embry-
onic development at E14.5, whereas in Lsr knockout embryos 
the BBB fails to seal and is leaky to small molecule tracers. 
We further demonstrate that in experimental autoimmune en-
cephalomyelitis (EAE) and middle cerebral artery occlusion 
(MCAO), murine models of neurological disorders in which 
BBB is disrupted, LSR is down-regulated in CNS ECs. Collec-
tively, these data identify a critical role of LSR for proper BBB 
formation and function.
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The importance of Lsr gene inactivation for 
BBB formation
To understand the physiological role of LSR at the BBB, we 
compared the structure and function of CNS ECs in Lsr/, 
Lsr+/, and Lsr+/+ mice. Lsr/ mice have been previously gen-
erated and display embryonic lethality before E15.5 (Mesli 
et al., 2004). Lsr/ embryos have a smaller liver and present 
dorsal skin detachment, but the exact cause of death remains 
unclear. Lsr+/ mice are born in a Mendelian ratio but have high 
plasma triglyceride and cholesterol levels during the postpran-
dial phase (Yen et al., 2008).
The key question is to determine whether the barrier func-
tion of the CNS blood vessels is compromised in the Lsr/ or 
Lsr+/ embryos. To determine if small molecules can cross the 
BBB in Lsr/ or Lsr+/ embryos, we developed a method to as-
sess BBB permeability to dyes in dissected embryos. It has been 
demonstrated that the BBB is functional during embryogenesis 
(Daneman et al., 2010b; Ben-Zvi et al., 2014); here we performed 
a time course examining precisely at which time point the BBB 
seals during embryonic development. To achieve this, we per-
formed tracer injections on dissected embryos to determine the 
time course of BBB leakage during early embryogenesis. We 
performed Caesarean sections of pregnant females, extracted 
 splice variant translates a full-length protein that has an exter-
nal C terminus, a transmembrane domain, and a cytoplasmic 
N-terminal tail. The  and  splice variants lack a putative 
dileucine signal, and the  lacks almost the entirety of the trans-
membrane domain. The association of // is important in 
the binding of lipoproteins in the liver (Yen et al., 1999, 2008). 
We assessed LSR splice variant composition in purified CNS 
ECs by qRT-PCR and identified that the main LSR splice vari-
ant is  followed by  and lastly  (Fig. 1 C). No LSR mRNA 
was detectable in purified liver ECs, which is consistent with 
the immunohistochemistry results (Fig. 1 A). We confirmed 
this data by Western blot analysis on purified mouse brain 
capillaries (Fig. 1 D) where the main band corresponds to  
(64 kD), the  band has a lower density (66 kD), and the  has 
the weakest signal (58 kD). To compare LSR splice variant 
expression between different organs, we performed qRT-PCR 
from whole brain, lung, and liver (Fig. 1 C). In the liver, LSR is 
expressed primarily in hepatocytes, with  being the main LSR 
variant, followed by  and , similar to the brain but with much 
higher expression levels. In the lung, LSR is expressed in epi-
thelial cells, with  being the main LSR splice variant followed 
by  and then . This structural difference might define a dis-
tinct function of LSR in different cell types.
Figure 1. LSR expression in adult mice. (A) Tissue sections of brain, lung, liver, and intestine were colabeled with antibodies directed against LSR (red) and 
CD31 (green, to label blood vessels). Expression of LSR in CD31+ ECs is only observed in the brain. Bar, 100 µm. (B) Tissue sections from adult mice were 
labeled with the blood vessel marker BSL I (green), and antibodies against occludin (blue, bicellular TJ) and LSR (red). The merged image indicates that in 
CNS blood vessels LSR is localized at the tricellular TJ where two bicellular TJ meet. Bar, 5 µm. (C, left) Quantitative real-time PCR analysis of LSR isoforms 
from purified brain ECs and liver ECs. Analysis indicates no detectable LSR expression in liver ECs but high expression of the  variant followed by  and 
 variants in brain ECs. (C, middle and right) Quantitative real-time PCR analysis of LSR variants from whole brain, lung, and liver. The expression in liver is 
much higher than brain or lung, and thus was given its own y axis (right). Splice variant composition is similar between brain and liver (’ variant followed 
by  and  variants) but different in the lung ( variant followed by ’ and  variants). Data represent means ± SD (error bars) from three indipendent 
experiments. (D) Western blot profile of LSR from purified brain capillaries shows a stronger band for the  splice variant followed by  and .
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Figure 2. LSR expression during embryogenesis. 
Tissue sections of E11.5 (top), E12.5 (middle), 
and E13.5 (bottom) mouse embryos were stained 
with antibodies directed against LSR (red) and 
CD31 (green). Whole embryos, as well as high-
power images of three CNS regions (caudal SC, 
rostral SC, and forebrain), are shown as well as 
single-channel images for LSR staining. At E11.5, 
LSR staining is visualized in CNS blood vessels 
at the caudal part of the SC only. By E12.5, LSR 
is expressed throughout the caudal-to-rostral axis 
of the SC, but not in the forebrain. At E13.5, LSR 
is expressed in all blood vessels throughout the 
CNS. Bars: (left) 1.25 mm; (right) 20 µm.
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from E14.5 to E16.5. Thus, the BBB is permeable for the first 
few days after the initiation of CNS angiogenesis, then it seals 
to this small molecule starting at E14.5. Interestingly, this is 
similar to the time course of LSR expression in the vessels. To 
confirm that our method doesn’t disrupt the vasculature, we in-
jected 10 kD rhodamine-dextran in E12.5 LSR embryos. Fig. S2 
reveals minimal leakage in any of the genotypes. Thus, at E12.5, 
CNS ECs are permeable to small molecules but have low per-
meability to large molecules. These results confirm that our 
method can be used to assess BBB permeability in embryos 
without disruption of vascular integrity.
Next, we examined whether LSR expression is neces-
sary for BBB sealing during embryogenesis. We examined the 
single embryos that remained attached to the placenta, and in-
jected dyes into their heart using a glass capillary needle con-
nected to an automated syringe pump. We only analyzed data 
from living embryos by ensuring that the heartbeat was main-
tained throughout the experiment. Any embryo whose heart 
stopped beating during the experiment was not analyzed. We 
used Sulfo-NHS-biotin (446 D) as a molecular tracer and ana-
lyzed leakage by staining tissue sections with a fluorophore-
conjugated streptavidin.
We first performed a time course of biotin leakage in 
wild-type embryos to examine BBB permeability of embryos 
from E12.5 to E16.5 (Fig. 3 A). This analysis reveals that the 
dye leaks through the BBB until E13.5 but is greatly restricted 
Figure 3. BBB phenotype of LSR embryos. (A) Quantification of Sulfo-NHS biotin leakage through the BBB of wild-type embryos at different ages. At E12.5 
and E13.5, biotin leaks through the BBB. From E14.5 and onwards, leakage of Sulfo-NHS biotin is greatly restricted. (B) Quantification of BBB leakage of 
Sulfo-NHS biotin in Lsr+/+, Lsr +/, and Lsr / embryos at E12.5, E13.5, and E14.5. At E12.5 and E13.5, Sulfo-NHS biotin leakage is comparable between 
the genotypes. However, at E14.5 Sulfo-NHS biotin leakage is greatly diminished in Lsr+/+ and Lsr+/, but not Lsr/, mice. Data represent mean ± SEM 
(error bars). ***, P < 0.0001. (C) Visualization of BBB leakage of Sulfo-NHS biotin in Lsr+/+, Lsr+/, and Lsr/ E14.5 embryos. PFA fixed tissue sections of 
E14.5 Sulfo-NHS biotin-injected embryos were stained with fluorophore (Alexa Fluor 488)-conjugated streptavidin. Lsr+/+ (left) and Lsr+/ (middle) embryos 
present minimal leakage of Sulfo-NHS biotin from the blood vessels into the SC, whereas the dye is observed throughout the neural tissue of Lsr/ (right) 
embryos. Bar, 20 µm. (D) Fresh-frozen tissue sections of E13.5 mouse SC from Lsr+/+ (top), Lsr+/ (middle), and Lsr/ (bottom) embryos were labeled with 
an anti–claudin 5 antibody (red) and CD31 to stain blood vessels (green). There was no discernable difference in the claudin 5 expression level or local-
ization between genotypes. Bar, 20 µm. (E) Quantification of TJ protein (LSR, Zo1, Occludin, Cldn5) expression in E14.5 CNS Lsr+/+, Lsr+/, and Lsr/ 
embryos. This graph shows no significant differences for levels of Zo1, occludin, and claudin 5 between genotypes. Data represent mean ± SD (error bars). 
n is between 3 and 6. (F) Quantification of albumin leakage through the BBB of Lsr+/+, Lsr+/, and Lsr/ embryos from E12.5 to E14.5. There was no 
significant difference in leakage of albumin into the brain between genotypes at any age. Data represent mean ± SD (error bars). n is between 3 and 8. 
(G) Electron micrograph of SC blood vessels from E14.5 Lsr+/+ and Lsr/ embryos. Arrowheads indicate kissing points of TJs. There were no discernable 
differences in the ultrastructure of TJs between genotypes. Bar, 50 nm.
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TJ proteins might not only be involved in sealing an epi-
thelium or endothelium; they might have other functions. By 
using different fixation methods (PFA fixed tissue), LSR ex-
pression has been visualized in specific neuronal subpopula-
tions (Stenger et al., 2012b). By performing filipin staining, 
the authors demonstrated an increase in membrane-associated free 
cholesterol in specific brain regions of 18-mo-old Lsr+/ mice 
compared with wild-type controls. This result suggests that 
LSR might be important for cholesterol distribution within the 
brain, where it localizes in membranes of glial cells and neurons, 
and in myelin sheets (Dietschy and Turley, 2001). We performed 
a filipin stain on E14.5 LSR embryos and examined the choles-
terol distribution in the CNS. The staining was homogeneous 
between Lsr/, Lsr+/, and Lsr+/+ embryos (unpublished data), 
and quantification showed no difference in membrane-associated 
free cholesterol between the groups (Fig. S3). At this age, the 
whole brain cholesterol concentration is very low (<2 mg/g 
compared with 20 mg/g in adults), which might explain why no 
difference was observed (Dietschy and Turley, 2004).
LSR expression in neurological disorders
BBB disruption is a common component of many different neu-
rological diseases including MS, stroke, trauma, and neurode-
generative disorders (Daneman, 2012). Therefore, identifying 
the mechanisms that lead to this disruption may lead to thera-
peutics that limit the progression of these diseases. Here, we 
examined LSR expression during EAE, a mouse model of MS, 
and following a transient MCAO/reperfusion (MCAO) mouse 
model of stroke.
4 d after the onset of symptoms of EAE, we compared 
inflammatory lesions to unaffected white matter in the mouse 
SC (Fig. 4 A). Co-labeling of immune cells (CD45) and endog-
enous IgG identified the locations where blood vessels had be-
come inflamed and leaky. In these inflammatory lesions, LSR 
was significantly down-regulated (38 ± 3%) compared with 
blood vessels in unaffected regions within the same tissue sec-
tion (Fig. 4 B). This suggests that BBB breakdown during EAE 
is associated with loss of tricellular TJ proteins.
For MCAO, mice were subjected to 2 h of occlusion of 
the middle cerebral artery followed by a 24-h reperfusion pe-
riod. We localized the leaky blood vessels in the injured hemi-
sphere by perfusing mice with biotin and then staining the 
brain sections with a fluorophore-conjugated streptavidin dye (to 
image the leakage; Fig. 4 C) and CD31 (to stain ECs; Fig. 4 C). 
After selecting areas of vascular leakage in the ipsilateral hemi-
sphere and their nonleaky vessel counterparts in the contralat-
eral hemisphere, we performed a stain for LSR and focused 
our observations in the selected area (Fig. 4 D). We observed 
a significant down-regulation of LSR in the ipsilateral hemi-
sphere (Fig. 4 E). These results suggest that loss of the tricellu-
lar TJ protein LSR is associated with BBB breakdown after 
acute MCAO.
In conclusion, we have shown that LSR is specifically 
expressed at the tricellular TJs of CNS blood vessels with an 
expression that follows BBB maturation. As previously re-
ported, Lsr knockout mice are embryonic lethal (Mesli et al., 
2004), and we have identified that the CNS blood vessels of 
morphology of CNS blood vessels at a time point where LSR 
is expressed throughout the embryo, E13.5. CD31 staining of 
whole mount embryos didn’t reveal any major differences in 
the length, branching, or overall structure of CNS blood ves-
sels or hemorrhage (unpublished data). We then examined the 
time course of BBB permeability in Lsr+/+, Lsr+/, and Lsr/ 
mice (Fig. 3 B). In Lsr+/+ and Lsr+/ mice, the BBB is highly 
permeable to Sulfo-NHS-biotin at E12.5 and E13.5, but forms 
a much more restrictive barrier by E14.5. In contrast, in Lsr/ 
mice the BBB is highly permeable to the tracer at E14.5 
(Fig. 3, B and C), demonstrating that LSR is required for the 
sealing of the BBB. Interestingly, the BBB of Lsr/ mice had 
minimal permeability to large endogenous proteins, including 
albumin (69 kD; Fig. 3 F), antibodies (160 kD), and fibrinogen 
(52 kD; unpublished data). Thus, there is a size-selective perme-
ability defect of the BBB in LSR-deficient mice, similar to the 
one described for Cldn5 knockout mice. This suggests a com-
mon phenotype when disrupting bicellular and tricellular TJs, 
where leakage of small molecules probably occurs through the 
paracellular barrier, and therefore it seems that leakage of larger 
molecules may require transcellular vesicle–mediated pathways 
rather than paracellular pathways. It is important to note that in 
this mouse model, Lsr is deleted throughout the organism, and 
thus it remains possible that the leakage of the BBB is secondary 
to the role of LSR in other cell types, including the liver, as liver 
failure has been shown to lead to BBB disruption (Thumburu 
et al., 2012). Electron microscopy studies will be required to 
determine through which part of the ECs the small molecules 
leak in LSR-deficient mice. We have also examined BBB per-
meability in Lsr+/ adult mice brains and did not find any leak-
age of a biotin tracer (unpublished data), which indicates that 
one copy of Lsr is sufficient to seal the BBB throughout life.
We then studied the effect of Lsr deletion on the expres-
sion of bicellular TJ proteins. At the BBB, claudin 5, occludin, 
and ZO1 are the main bicellular TJ proteins (Sohet and Daneman, 
2013). We performed immunostaining of these TJ proteins on 
tissue sections of E13.5 (unpublished data) and E14.5 Lsr/, 
Lsr+/, and Lsr+/+ mouse embryos and focused our observations 
on the blood vessels of the SC. We observed no difference in 
expression or localization of claudin 5 protein between Lsr/, 
Lsr+/, and Lsr+/+ embryos at both ages (Fig. 3 D). Similarly, we 
found no difference in the expression or localization of occludin 
and ZO1 (Fig. 3 E). We have also examined each bicellular TJ 
protein in Lsr+/ and Lsr+/+ adult mouse brain tissue sections 
and did not find any differences (unpublished data).
For a more precise analysis of the junctional complex ar-
chitecture, we performed electron microscopy on Lsr/ and 
Lsr+/+ E14.5 embryos. When focusing on EC adhesions, we ob-
served TJs with kissing points in both Lsr/ and Lsr+/+ embryos 
with no discernable structural difference (Fig. 3 G). Therefore, 
removing LSR from the junctional complex doesn’t disrupt the 
ultrastructure of the TJs. This is similar with the electron mi-
croscopy data from the study by Nitta et al. (2003), where they 
described no ultrastructural differences between the CNS EC 
TJs in Cldn5 knockout mice and their wild-type littermates. 
Thus, changes in BBB permeability can occur without changes 
to the ultrastructure of the junction.
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neurological disorders. Collectively, these data suggest that 
the expression of tricellular TJ proteins by CNS ECs may be a 
key determinant in the formation of a high-resistance paracel-
lular barrier.
Materials and methods
Antibodies
All antibodies are commercially available: rabbit anti-LSR (HPA007270; 
Sigma-Aldrich), rabbit anti–claudin 5 (34-1600; Invitrogen), rat anti-
CD31 antibody (553370; BD), rabbit (40-4700; Invitrogen) and mouse 
(33-1500; Invitrogen) anti-occludin, mouse anti-ZO1 (33-9100; Invitrogen), 
rabbit anti-albumin (PA1-28339; Thermo Fisher Scientific), biotinylated rat 
anti-CD45 (557460; BD), and rabbit anti-fibrinogen (ab34269; Abcam). 
Lsr/ mice appear morphologically normal with no difference 
in bicellular TJ protein localization and permeability for large 
endogenous molecules as compared with Lsr+/+ embryos. We 
have observed that wild-type embryos have leakage to small 
molecules for the first few days after cerebral angiogenesis, 
and that this barrier seals by E14.5; however, this barrier does 
not seal in Lsr-deficient embryos. This reveals an important 
role of LSR in proper BBB function and formation. In ex-
perimental models with a disrupted BBB, such as EAE and 
MCAO, LSR is down-regulated in leaky blood vessels. These 
results demonstrate that LSR is a BBB-enriched TJ protein 
that is necessary for proper BBB formation, and it is down-
regulated during pathological BBB leakage associated with 
Figure 4. LSR expression during EAE and MCAO. (A) LSR expression in mouse SC at 4 d after onset of symptoms after induction of EAE. Tissue sections 
of mouse SC were labeled with antibodies against CD45 (magenta), CD31 (green), endogenous IgG (white), and LSR (red). The broken lines demarcate 
the inflammatory lesion on the right and the noninflamed region on the left, with larger images for LSR staining (top) and merge picture (bottom). LSR is 
down-regulated in inflamed blood vessels. Bars, 50 µm. (B) Quantification of LSR expression in blood vessels of inflamed and noninflamed regions after 
EAE induction. LSR expression is down-regulated in inflamed regions. Data represent mean ± SEM (error bars). ***, P < 0.0001. Unpaired t test. (C) Biotin 
leakage in mouse brain after MCAO. MCAO was performed on mice for 2 h, followed by 24 h of reperfusion. Mice were then anesthetized and given 
a transcardiac perfusion of PBS/biotin followed by PFA. Tissue sections were stained for CD31 (green) and streptavidin–Alexa Fluor 594 (to label biotin). 
Whole brain sections were digitally reconstructed to visualize biotin extravasation. The broken line in the center separates the contralateral hemisphere (left) 
from the ipsilateral side (right). Boxes indicate where pictures were taken for LSR measurement in D. Bar, 0.5 mm. (D) LSR expression in mouse brain 24 h 
after reperfusion after MCAO. Tissue sections of mouse brains were colabeled for LSR (red) and blood vessels (BSL, green) in the contralateral (top) and ipsi-
lateral (bottom) hemispheres. Bar, 50 µm. (E) Quantification of LSR expression in the contralateral and ipsilateral hemispheres after MCAO. LSR expression 
is down-regulated in the ipsilateral hemisphere. Data represent mean ± SEM (error bars). *, P < 0.05. Unpaired t test.
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dissected, fixed in 4% tannic acid, stained in 2% OsO4 for 1 h followed by 
2% uranyl acetate for 1 h, and finally dehydrated in ethanol and embedded 
in epoxy resin. Ultrathin sections were cut and images were then acquired at 
120 kV with a 1400 transmission electron microscope (JEOL).
EAE
C57BL/6 mice were subcutaneously injected with 200 µl of an emulsion of 
Complete Freund’s adjuvant, MOG35-55 peptide, and inactivated myco-
bacterium tuberculosis (EK-2110; Hooke Laboratories). 2 h and 24 h after-
wards, 200 ng of Pertussis toxin was injected i.p. (EK-2110; Hooke 
Laboratories). At 4 d after onset of symptoms, mice were perfused with 
DPBS, and their SCs were dissected and frozen in OCT. 10-µm sections 
were generated. Staining for LSR, CD45, CD31, and endogenous mouse 
IgG was performed as described in “Immunohistochemistry.”
MCAO
A transient MCAO was performed in young adult C57BL/6 mice as de-
scribed previously (Kokubo et al., 2002). In brief, a monofilament suture 
was inserted into the right external carotid artery. After 2 h of occlusion, 
the suture was removed. After 24 h of reperfusion, mice were perfused 
with DPBS followed by a solution of Sulfo-NHS-biotin (0.5 mg/ml), and 
their brains were dissected and bisected coronally. Half of each brain was 
fresh-frozen in OCT for LSR staining and the other half was postfixed for 2 h 
in 4% PFA for biotin labeling, cryopreserved in 30% sucrose, and frozen in 
a 2:1 solution of 30% sucrose/OCT. 10-µm sections were generated.
Quantifications
All quantifications were performed using Image J. To quantify leakage of 
endogenous molecules, the intensity of 10 different regions outside of the 
blood vessels was measured. The signal average was normalized to the 
average signal for wild-type embryos. To quantify TJ protein expression, 
the intensity of 10 different regions of blood vessels was measured for each 
TJ protein. The signal average was normalized to the average signal for 
wild-type embryos. To quantify leakage of biotin, the average signal inten-
sity measured from 10 different regions outside of the blood vessels was 
normalized to the average signal intensity measured from 10 different re-
gions inside the blood vessels.
Online supplemental material
Fig. S1 shows a detailed LSR expression in large vessels of the brain, at the 
choroid plexus, in a CVO organ, and during postnatal days. Fig. S2 shows 
SC tissue sections in E12.5 LSR embryos injected with a 10-kD dextran-
rhodamine dye, and a graph showing leakage quantification. Fig. S3 shows 
a graph representing quantifications of the filipin staining in SC of E14.5 
LSR embryos. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201410131/DC1.
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